A prospective, controlled and randomized clinical study assessing the effectiveness and safety of Co-ad ministration of intravitreal Dexamethasone implant and silicon oil endotamponade for proliferative diabetic retinopathy with tractional diabetic macular edema
Latest Information Update: 15 Dec 2021
At a glance
- Drugs Dexamethasone (Primary) ; Ranibizumab
- Indications Diabetic macular oedema; Diabetic retinopathy
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Dec 2021 New trial record